KORSANA BIOSCIENCES INC
KRSANASDAQ🏆 #3795 by market capUS Equity
——
Quote unavailableTrack KRSA
Get earnings, price moves & breaking news on Telegram
24h—
7d—
14d—
30d—
ytd—
1y—
🏦Market Cap
$141M
Small Cap
📈Revenue Growth (YoY)
3.7%
Slowing
📊Gross Margin
61.6%
High
💵FCF Margin
-234.3%
Thin
⚖️P/S Ratio
74.1x
Expensive
Otter Score
—
Insufficient data
No chart data available for KRSA.
Trading Snapshot
- Day Range
- —
- 52-Week Range
- $7.19 – $59.36
- Volume (shares)
- —
- Avg Volume (shares)
- —
- Shares Outstanding
- 4.7M
- Next Earnings
- —
Fundamentals Snapshot
- Annual Revenue
- $2M
- Last Q Revenue
- —
- P/E Ratio
- -2.5
- P/S Ratio
- 74.1x
- EPS (TTM)
- $-11.04
- Dividend Yield
- 0.00%
- Dilution (1yr)
- +26.7%
KORSANA BIOSCIENCES INC
KRSAFinancial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$2M▲ +3.7% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
100.0%▲ +0.0% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
−$5M▲ +37.1% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
−$3M▼ −23.5% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
461K▲ +26.7% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
$3M▲ +$8K YoY
StockOtter · stockotter.spaceAbout KORSANA BIOSCIENCES INC
Cyclerion Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of human therapeutics. Its product pipeline includes several sGC stimulators, small molecules that act synergistically with nitric oxide on sGC to boost production of cyclic guanosine monophosphate. The company was founded on September 6, 2018 and is headquartered in Cambridge, MA.
🦦
Otter Score Breakdown
How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)Insufficient data for all five components.
💎Quality★★★★★
🚀Growth★★★★★
⚖️Valuation★★★★★
💧Dilution★★★★★
Overall Score
Insufficient data
—/100
Analyst data unavailable.
Latest News & Updates
News unavailable.